4//SEC Filing
Gault Laura 4
Accession 0001562180-24-006089
CIK 0001597553other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:05 PM ET
Size
8.6 KB
Accession
0001562180-24-006089
Insider Transaction Report
Form 4
Gault Laura
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-08-05$8.96/sh−3,288$29,460→ 10,737 total - Award
Common Stock
2024-08-05+13,500→ 14,025 total
Footnotes (2)
- [F1]On February 13, 2024, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 33,750 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on August 5, 2024, resulting in the vesting of the PSUs as to 13,500 shares.
- [F2]Reflects beneficial ownership balance which includes 298 shares purchased on June 28, 2024 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001951944
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 4:05 PM ET
- Size
- 8.6 KB